Compare FBGL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBGL | BFRI |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | Singapore | United States |
| Employees | N/A | 93 |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 10.6M |
| IPO Year | N/A | N/A |
| Metric | FBGL | BFRI |
|---|---|---|
| Price | $0.75 | $0.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 1.4M | 124.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.37 |
| Revenue Next Year | N/A | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.54 |
| 52 Week High | $1.40 | $1.18 |
| Indicator | FBGL | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 49.24 |
| Support Level | $0.55 | $0.81 |
| Resistance Level | $0.78 | $0.90 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 38.21 | 39.39 |
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.